Evogene has released its earnings call transcript for the first quarter of 2026, revealing a financial loss during this period. Despite the reported loss, the company's stock experienced a rise of 1.95%. The earnings call provided insights into the company's performance and future outlook, which may have contributed to the positive reaction in the stock market.
Don't miss out on breaking stories and in-depth articles.
